San Francisco
Lisa partners with companies of all stages to refine their policies and practices—with a goal of deterring unnecessary litigation. Lisa strives to gain in-depth knowledge of the culture and business goals of her clients, so she can be responsive and efficient.
Lisa has significant experience advising employers on complex issues, including wage and hour compliance and audits, worker classification, disability accommodation, employee leaves, commissions and bonuses, misappropriation of trade secrets, employment agreements, onboarding, employee discipline and terminations, and managing and/or conducting sensitive workplace investigations.
As a litigator of high-stakes employment cases, Lisa secured many victories for her clients, including a complete defense verdict in a disability discrimination arbitration, dismissal of a disparate impact age discrimination claim in a collective action brought against a high-profile tech client, and successful oppositions to motions to certify wage and hour classes. Lisa’s background as an employment litigator helps her identify issues for her clients before they become a problem.
Before attending law school, Lisa worked as a journalist covering law and policy. Her work has appeared in The Wall Street Journal, The New York Times, CNET, and Bloomberg. Lisa draws upon this experience to guide clients with strategic internal and external messaging when complicated legal challenges arise.
San Francisco
Amanda works on matters involving trademark and patent infringement, as well as trade secret disputes in both state and federal court. In her commercial practice, she works with technology companies on contract disputes and issues arising under Section 230 of the Communications Decency Act.
Amanda also has a robust pro bono practice and has earned High Honors through the DC Courts' Capital Pro Bono Honor Roll.
Amanda graduated with honors from The George Washington University Law School. While in law school, she externed with the Department of Justice Civil Division's IP Litigation Section.
Prior to law school, Amanda worked as a paralegal and investment management analyst at another large international firm, where she worked on regulatory and transactional matters involving mutual funds and registered investment advisers.
San Francisco
San Francisco
Andraya represents companies throughout different stages of litigation across a range of areas, with a focus on the technology, energy, and finance sectors.
Prior to joining Orrick, Andraya clerked for the Honorable Paul J. Kelly, Jr., of the United States Court of Appeals for the Tenth Circuit. While in law school, she externed for the Honorable Jon E. DeGuilio of the United States District Court for the Northern District of Indiana. Andraya earned her law degree from Notre Dame Law School where she served as the Executive Notes Editor for the Notre Dame Law Review.
San Francisco
Jennifer works with life sciences clients in the areas of genomics, genome editing, antibody therapeutics, immuno-oncology therapies, cell-based therapies, protein therapeutics, antisense technologies, and pharmaceutical compositions and formulations. She has experience in preparing and prosecuting US and foreign patent applications, strategic counseling and managing global patent portfolios, and performing due diligence, freedom to operate, and patentability analyses.
Prior to joining Orrick, Jennifer was a senior patent agent at a large national law firm in San Francisco.
Before becoming a patent agent, Jennifer was a postdoctoral fellow at the Gladstone Institute of Cardiovascular Disease and she investigated cardiomyocyte differentiation from stem cells. Her doctoral studies at the Salk Institute for Biological Studies focused on transcriptional regulatory systems during organ development. She has co-authored peer-reviewed journal articles in the fields of genetics, molecular biology and cell biology.
Silicon Valley
Jared's prior experience includes financial services and due diligence work at a global consulting firm. While in law school, Jared clerked for a boutique law firm in Silver Spring, MD, as well as completed internships with the U.S. Attorney's Office for the District of Columbia, National Security Section and the Department of Justice's Tax Division, Financial Litigation Unit.
Paris
Hugues advises on the development and financing of international projects, with a particular focus on Africa and Europe. He has extensive experience advising sponsors (investors and industrialists), developers, and lenders (export credit agencies, commercial lenders, and development banks), particularly in the energy, infrastructure, and natural resources sectors.
Hugues regularly works on transactions in Africa. Through his involvement in numerous large-scale projects, he has acquired in-depth expertise in various national and regional legal systems and regimes, particularly those of the Economic Community of West African States (ECOWAS), the Central African Economic and Monetary Community (CEMAC), the West African Economic and Monetary Union (WAEMU), and the Organization for the Harmonization of Business Law in Africa (OHADA).
Hugues is also the author of numerous legal articles published in renowned law journals such as Lexis Nexis (France and Morocco), the Revue de droit bancaire et financier, the Revue Banque, and the Revue Contrats et Marchés Publics. In addition, he co-edits the annual editions of Lamy Droit du Financement and L’Essentiel Droits Africains des Affaires (Lextenso). He has also published the first book devoted to Islamic project financing.
Boston
Albert is involved in a broad range of corporate legal engagements for high growth technology companies, including IPOs, follow-on public offerings, private and public company securities law compliance matters, public company disclosure obligations, venture financings, mergers and acquisitions, de-SPAC transactions and SPAC IPOs. He also regularly advises public and private companies and their boards of directors on corporate governance issues.
Albert's clients include public and private companies in technology, energy, automotive, Internet related industries, real estate, finance and the life sciences (including, among others, immuno-oncology, gene therapy, restorative cell therapy and medical device companies). He also represents underwriters in initial public offerings, follow-on offerings and PIPE offerings and venture capital firms in a variety of investment transactions.
Albert was named to the Deal’s Top Rising Stars 2021 list, which recognizes top new partners at U.S. law firms who are “doing spectacular work in the field of deal-making and who have continued to progress in their career despite the obstacles put in front of them.”
Washington, D.C.
Behn advises gaming and gambling providers, large media companies, Fintech, blockchain and more traditional financial services participants, and other technology and consumer-focused companies on issues at the intersection of gaming, financial services, data privacy and governance and related regulatory areas. Clients turn to him for his ability to advise on the whole frame of issues they may encounter, and he is equally comfortable guiding emerging companies in the early stages of their lifecycles and mature, multinational public companies. Behn is at home in the courtroom – representing clients in cutting-edge gaming litigations, before regulatory bodies – helping the crypto industry address growing sanctions and other financial services obligations, and in the boardroom – assisting in the formation of significant commercial partnerships, brand licenses, acquisitions and other combinations.
New York; Silicon Valley
New York; Silicon Valley
Stephen’s practice focuses on the representation of life science, medical device, health IT, and other technology companies in transactional matters, including public and private financings, licensing, collaborations and strategic alliances, and mergers and acquisitions. He also represents venture capital firms in public and private financing transactions.
Stephen is recognized as a Leading Life Sciences Lawyer by LMG Life Sciences in their 2021/2022 rankings and short-listed as Venture Capital Attorney of the Year. He has served as a member of the Board of Tech Council of Maryland, the leading technology and life science association in that state, and of BayBio, Northern California’s leading life sciences association. Stephen is a frequent speaker on venture capital financings and served on the faculty at the 2005 and 2007 Emerging Entrepreneurs workshops at Stanford University.
Prior to joining Orrick, Stephen was a partner at Morrison & Foerster, Venture Law Group and Heller Ehrman. He began his legal practice as a litigator, focusing on securities and intellectual property. He also served as a law clerk to the Hon. Vaughn R. Walker in the United States District Court in the Northern District of California. Stephen graduated Order of the Coif from Stanford Law School, where he was managing editor of the Stanford Law Review, and graduated magna cum laude from Harvard College in Biology.
Washington, D.C.
Thora works with medical device, pharmaceutical, biotech and digital health companies, helping them navigate the increasingly complex patchwork of state and federal health privacy laws. One client described her to the Legal 500 as a “very practical” advisor providing “exceptional guidance” on health information privacy and HIPAA compliance matters.
Her breadth and depth of experience enable Thora to assist clients in harnessing the power of artificial intelligence and executing data-sharing arrangements, all while protecting health data. As a result, Thora spends much of her time counseling pioneering startups and high-growth companies on responsible innovation in healthcare and life sciences.
Thora brings extensive experience counseling clients, including Fortune 500 companies and brick and mortar providers, on the Health Insurance Portability and Accountability Act (HIPAA) and other state and federal health privacy and regulatory compliance regimes including:
Thora routinely helps companies and large employers prepare for and respond to privacy and security incidents involving health information. She also defends clients in government investigations initiated by the OCR, OIG, DOJ, FTC and State AGs, among others.
Washington, D.C.
Georgia also has extensive experience in assisting clients with product recalls, crisis management and government enforcement. Her practice in this sector includes assisting manufacturers, distributors, retailers and importers on all types of FDA regulated products including pharmaceuticals, medical devices and software, wearables, health and wellness products, cosmetics, cell and plant based foods, conventional foods, ag tech, compounded drugs, and dietary supplements.
Georgia’s deep experience and ability to provide practical guidance in FDA and FDA-adjacent regulatory matters allows her to work closely with innovative companies looking to minimize regulatory burdens and maximize U.S. marketing opportunities in the life science and health tech industry verticals. She also conducts regulatory due diligence for private equity and public company transactions involving life science, medtech and innovative companies.
Georgia is a frequent speaker at conferences and events who contributes regularly to leading trade and consumer media outlets.
Washington, D.C.
A substantial part of Shari’s practice involves aiding life sciences (pharma, medical device, and biologic) and healthcare companies with internal investigations and working with clients on compliance with government investigations, subpoenas, and investigative demands, as well as the defense of whistleblower qui tam suits involving the False Claims Act and the Anti-Kickback Statute. Shari has also managed litigations and helped lead trial teams involving diverse fields of science and technology including pharmaceuticals, various medical fields, and seals used in the semiconductor industry. She specializes in mastering complicated science and technologies and explaining them to judges and juries.
Shari regularly represents companies with FDA-regulated products and healthcare companies on strategic regulatory counseling matters. She also regularly conducts regulatory due diligence for private equity funds, acquirers, sellers, and underwriters in corporate transactions.
Shari also has substantial experience advising clients on complex advertising/promotion issues, including claim substantiation, disputes before the National Advertising Division of the BBB National Programs (NAD), and advertising lawsuits under Section 43(a) of the Lanham Act. She also regularly advises consumer product companies on Consumer Product Safety Commission related compliance.
Upon graduation from Harvard Law School, Shari clerked for the Honorable Frank A. Kaufman, United States District Court for the District of Maryland, who sat by designation on the U.S. Courts of Appeals for the Federal Circuit, the Fourth Circuit, the Seventh Circuit, and the Eleventh Circuit.